Small-medium enterprises in the pharmaceutics sectors play a major role in innovation within the industry. However, the financial constraints are generally so limiting that most of these organisations have not really been able to scale up their production and license …
India’s oncology pharma market, one of the most significant in global anti-cancer treatment, is thought to be suffering due to mighty supply chain challenges. Approximately 50 percent of all oncology drugs in India are brought in from other countries, with …
Choosing a pharmaceutical company that produces high-quality oncology medicines is crucial, especially as the demand for cancer treatment surges. In India, one in nine individuals is diagnosed with cancer in their lifetime, with each case presenting unique challenges. Meeting the …
India has become a key distributor of oncology medicines in the last few years. It is still growing, with expectations to reach up to USD 1.49 billion between 2024 and 2028. The government’s ease of approval for new formulations, the …
Are you aware of how India contributes to a world victory in the war against cancer? Oncology drug manufacturers in India are spearheading efforts to make quality, accessible cancer drugs globally. Demand for affordable oncology medicines is surging in India …
The pharma contract manufacturing industry is expected to experience tremendous growth, increasing to $319.6 billion in 2029. This growth is attributed to the rising cost of drug development, increased demands for generics, and fast-paced technological advancement. With these changes shaping the industry, …
Is third-party manufacturing the future of pharma? Driven by a push toward cost-saving, specialization, and strict regulatory demands, the pharmaceutical industry is shifting gears fast. Global contract manufacturing is projected to grow from $344.92 billion in 2023 to $604.11 billion …
